5 March, 2014
A new parent company for the Chordate Group has been established. Chordate Medical Holding AB, a company registered in Sweden, now owns 100% of the shares in Chordate Medical AG, the Swiss company that hitherto has been the Group’s parent company.
Fredrik Juto, who has previously been CEO of subsidiary Chordate Medical AB, is now Executive Chairman of Chordate Medical Holding AB.
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.